Dermata Therapeutics (DRMA) Earnings Date & Reports
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DRMA is expected to report earnings to fall 24.32% to -56 cents per share on March 31
Q4'26
Est.
$-0.56
Q2'26
Missed
by $0.19
Q1'26
Beat
by $1.02
Q4'25
Missed
by $1.02
Q3'25
Missed
by $1.33
The last earnings report on August 11 showed earnings per share of -74 cents, missing the estimate of -55 cents. With 39.94K shares outstanding, the current market capitalization sits at 4.28M.